J Quitmann1, A Giammarco2, M Maghnie3, F Napoli3, I Di Giovanni4, C Carducci5, A Mohn4, M Bullinger2, R Sommer2. 1. Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany. j.quitmann@uke.de. 2. Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany. 3. Istituto Giannina Gaslini, Genova, Italy. 4. Fondazione Università "G.d'Annunzio", Chieti, Italy. 5. Ospedale Pediatrico Bambino Gesù, Rome, Italy.
Abstract
PURPOSE: The Quality of Life in Short Stature Youth (QoLISSY) questionnaire is a disease-specific instrument developed to assess health-related quality of life (HrQoL) in children with short stature. While the original instrument was simultaneously developed in five European countries, this study describes the results of the Italian QoLISSY translation, cultural adaptation, and validation. METHODS: Focus group discussions and a cognitive debriefing process with children (N = 12) diagnosed with growth hormone deficiency or idiopathic short stature and one parent each, as well as parents of younger children (N = 20) were conducted to examine the linguistic and content validity of the Italian version. Psychometric testing was performed using data from the subsequent field- and re-test (N = 32). RESULTS: The results of the qualitative testing of the Italian sample revealed comparability of content to data of the original five European countries. The following field- and re-test results were psychometrically satisfactory including good item and scale operating characteristics, sufficient evidence of reliability, and acceptable evidence of construct validity. CONCLUSION: In conclusion, the Italian QoLISSY HrQoL-dimensions are comparable to other European countries. The psychometric quality of the Italian QoLISSY version is satisfactory and the instrument is ready for use in Italian patients and their parents.
PURPOSE: The Quality of Life in Short Stature Youth (QoLISSY) questionnaire is a disease-specific instrument developed to assess health-related quality of life (HrQoL) in children with short stature. While the original instrument was simultaneously developed in five European countries, this study describes the results of the Italian QoLISSY translation, cultural adaptation, and validation. METHODS: Focus group discussions and a cognitive debriefing process with children (N = 12) diagnosed with growth hormone deficiency or idiopathic short stature and one parent each, as well as parents of younger children (N = 20) were conducted to examine the linguistic and content validity of the Italian version. Psychometric testing was performed using data from the subsequent field- and re-test (N = 32). RESULTS: The results of the qualitative testing of the Italian sample revealed comparability of content to data of the original five European countries. The following field- and re-test results were psychometrically satisfactory including good item and scale operating characteristics, sufficient evidence of reliability, and acceptable evidence of construct validity. CONCLUSION: In conclusion, the Italian QoLISSY HrQoL-dimensions are comparable to other European countries. The psychometric quality of the Italian QoLISSY version is satisfactory and the instrument is ready for use in Italian patients and their parents.
Entities:
Keywords:
Children and parents; Cultural adaptation; Health-related quality of life; Short stature
Authors: Monika Bullinger; Maria Kołtowska-Häggström; David Sandberg; John Chaplin; Hartmut Wollmann; Meinolf Noeker; Anna Levke Brütt Journal: Horm Res Date: 2009-08-18
Authors: Monika Bullinger; Julia Quitmann; Neuza Silva; Anja Rohenkohl; John E Chaplin; Kendra DeBusk; Emmanuelle Mimoun; Eva Feigerlova; Michael Herdman; Dolores Sanz; Hartmut Wollmann; Andreas Pleil; Michael Power Journal: Horm Res Paediatr Date: 2014-06-11 Impact factor: 2.852
Authors: P Cohen; A D Rogol; C L Deal; P Saenger; E O Reiter; J L Ross; S D Chernausek; M O Savage; J M Wit Journal: J Clin Endocrinol Metab Date: 2008-09-09 Impact factor: 5.958
Authors: Monika Bullinger; Rachel Sommer; Andreas Pleil; Nelly Mauras; Judith Ross; Ron Newfield; Lawrence Silverman; Anja Rohenkohl; Janet Fox; Julia Quitmann Journal: Health Qual Life Outcomes Date: 2015-04-02 Impact factor: 3.186
Authors: Monika Bullinger; Julia Quitmann; Mick Power; Michael Herdman; Emmanuelle Mimoun; Kendra DeBusk; Eva Feigerlova; Carolina Lunde; Maria Dellenmark-Blom; Dolores Sanz; Anja Rohenkohl; Andreas Pleil; Hartmut Wollmann; John E Chaplin Journal: Health Qual Life Outcomes Date: 2013-05-07 Impact factor: 3.186
Authors: M Castagno; A Monzani; S Zanetta; G Genoni; E Giglione; R Ricotti; G Bona; F Prodam; S Bellone Journal: J Endocrinol Invest Date: 2018-02-08 Impact factor: 4.256